Cargando…
How to evaluate the immune status of lung cancer patients before immunotherapy
Nowadays, cancer immunotherapy is a promising strategy in solid tumour treatment. It has become a breakthrough in achieving long-term survival in many advanced cases. The essence of modern immunotherapy is to improve the host antitumour immune defence. Currently, it is critically important to determ...
Autores principales: | Domagala-Kulawik, Joanna, Raniszewska, Agata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715360/ https://www.ncbi.nlm.nih.gov/pubmed/29225707 http://dx.doi.org/10.1183/20734735.001917 |
Ejemplares similares
-
Modulation of the immune response by heterogeneous monocytes and dendritic cells in lung cancer
por: Kwiecień, Iwona, et al.
Publicado: (2021) -
Lung Cancer Stem Cells—Origin, Diagnostic Techniques and Perspective for Therapies
por: Raniszewska, Agata, et al.
Publicado: (2021) -
Immunophenotype of T Cells Expressing Programmed Death-1 and Cytotoxic T Cell Antigen-4 in Early Lung Cancer: Local vs. Systemic Immune Response
por: Kwiecien, Iwona, et al.
Publicado: (2019) -
Immunomodulatory Molecules On Lung Cancer Stem Cells From Lymph Nodes Aspirates
por: Raniszewska, Agata, et al.
Publicado: (2020) -
Blood Monocyte Subsets with Activation Markers in Relation with Macrophages in Non-Small Cell Lung Cancer
por: Kwiecień, Iwona, et al.
Publicado: (2020)